E F Solomayer

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. ncbi Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
    E F Solomayer
    Department of Obstetrics and Gynecology, University of Heidelberg, Germany
    Breast Cancer Res Treat 59:271-8. 2000
  2. ncbi Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    E F Solomayer
    Department of Obstetrics and Gynaecology, University of Heidelberg, Germany
    Breast Cancer Res Treat 49:145-54. 1998
  3. ncbi Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients
    E F Solomayer
    Department of Obstetrics and Gynecology, University of Tubingen, Schleichstrasse 4, 72076 Tubingen, Germany
    Clin Cancer Res 7:4102-8. 2001
  4. ncbi Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up
    I J Diel
    Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
    Ann Oncol 19:2007-11. 2008
  5. ncbi Bisphosphonates and the prevention of metastasis: first evidences from preclinical and clinical studies
    I J Diel
    Department of Obstetrics and Gynecology, University Hospital, Heidelberg, Germany
    Cancer 88:3080-8. 2000
  6. ncbi Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    E F Solomayer
    Department of Obstetrics and Gynaecology, University of Heidelberg, Germany
    Br J Cancer 76:812-8. 1997
  7. ncbi Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies
    T Fehm
    Department of Obstetrics and Gynecology, University of Tuebingen, Calwerstrasse 7, 72076 Tuebingen, Germany
    Gynecol Oncol 112:605-9. 2009
  8. ncbi Impaired bone microenvironment: correlation between bone density and presence of disseminated tumor cells
    B Kraemer
    Department of Obstetrics and Gynecology, University of Tuebingen, Calwerstrasse 7, 72076 Tuebingen, Germany
    Anticancer Res 31:4423-8. 2011

Collaborators

  • I J Diel
  • M Hahn
  • T Fehm
  • B Kraemer
  • M Banys
  • D Wallwiener
  • C Mack
  • R Rothmund
  • N Krawczyk
  • H P Lipp
  • V Beck
  • M Krimmel
  • S Reinert
  • M Hairass

Detail Information

Publications8

  1. ncbi Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
    E F Solomayer
    Department of Obstetrics and Gynecology, University of Heidelberg, Germany
    Breast Cancer Res Treat 59:271-8. 2000
    ..The better prognosis of patients with bone metastases is not determined exclusively by hormone receptor status. The disease is significantly more stable in patients with first bone metastases than in those with first visceral metastases...
  2. ncbi Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    E F Solomayer
    Department of Obstetrics and Gynaecology, University of Heidelberg, Germany
    Breast Cancer Res Treat 49:145-54. 1998
    ..The detection of cathepsin D on disseminated tumour cells characterises a subgroup of patients with a poorer prognosis who should undergo more aggressive adjuvant systemic therapy...
  3. ncbi Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients
    E F Solomayer
    Department of Obstetrics and Gynecology, University of Tubingen, Schleichstrasse 4, 72076 Tubingen, Germany
    Clin Cancer Res 7:4102-8. 2001
    ..L. Mansi et al., Lancet, 354:197-202, 1999). We report data from 727 patients with a median follow-up period of 6.5 years...
  4. ncbi Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up
    I J Diel
    Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
    Ann Oncol 19:2007-11. 2008
    ..Adding oral clodronate to postoperative adjuvant breast cancer therapy significantly improves disease-free survival (DFS) and overall survival (OS). Long-term follow-up data from the prospective, randomized, controlled study are reported...
  5. ncbi Bisphosphonates and the prevention of metastasis: first evidences from preclinical and clinical studies
    I J Diel
    Department of Obstetrics and Gynecology, University Hospital, Heidelberg, Germany
    Cancer 88:3080-8. 2000
    ..As well as having an apoptotic and antiproliferative effect on osteoclasts, bisphosphonates may exert a similar influence on macrophages and tumor cells...
  6. ncbi Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    E F Solomayer
    Department of Obstetrics and Gynaecology, University of Heidelberg, Germany
    Br J Cancer 76:812-8. 1997
    ..For the first time, it was possible to evaluate an important qualitative parameter involved in the process of breast cancer metastases...
  7. ncbi Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies
    T Fehm
    Department of Obstetrics and Gynecology, University of Tuebingen, Calwerstrasse 7, 72076 Tuebingen, Germany
    Gynecol Oncol 112:605-9. 2009
    ..The aim of this study was to describe the incidence and risk factors of ONJ in patients with breast cancer or gynecological malignancies receiving bisphosphonates (BP)...
  8. ncbi Impaired bone microenvironment: correlation between bone density and presence of disseminated tumor cells
    B Kraemer
    Department of Obstetrics and Gynecology, University of Tuebingen, Calwerstrasse 7, 72076 Tuebingen, Germany
    Anticancer Res 31:4423-8. 2011
    ..An impaired bone microenvironment may lead to reduced bone density and osteoporosis affecting the BM as a homing site for DTCs. The bone mineral density (BMD) and its correlation to DTC in BM was evaluated...